Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mangoceuticals, Inc. ( (MGRX) ) has shared an announcement.
On August 26 and August 29, 2025, Mangoceuticals, Inc. entered into agreements with five accredited investors to sell 709,677 shares of restricted common stock at $1.55 per share, totaling $1,100,000. The shares were sold without public offering, underwriters, or agents, and include piggyback registration rights for one year. The securities are subject to transfer restrictions and were not registered under the Securities Act, relying on exemptions for accredited investors.
More about Mangoceuticals, Inc.
Average Trading Volume: 158,825
Technical Sentiment Signal: Hold
Current Market Cap: $24.86M
Learn more about MGRX stock on TipRanks’ Stock Analysis page.